Primary Record
ETK9IKM6NH
- In stock
- 8,710 g
- Purity
- 99.6 %
- CAS
- 127017-74-7
Compound Identifiers & Properties
- CAS
- 127017-74-7
- PubChem CID
- 71315281
- SMILES
- COC1=CC=C(C=C1)[C@@H]2CCNC[C@H]2COC3=CC4=C(C=C3)OCO4.Cl
- Canonical SMILES
- COc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1.Cl
Names & Synonyms
- ETK9IKM6NH
- Paroxetine EP Impurity B
- 127017-74-7
- UNII-ETK9IKM6NH
- rac-trans-4-Defluoro-4-methoxy Paroxetine Hydrochloride
- MS67NW26YG
- Paroxetine methoxy analog [USP]
- DTXSID10747434
- WGRXGIJCIOCNHB-NKGQWRHHSA-N
- BCP27834
- Paroxetine related compound A [USP]
- Paroxetine related compound A [USP-RS]
- Paroxetine Hemihydrate EP Impurity B HCl
- A899073
- Paroxetine Hydrochloride Hemihydrate EP Impurity B
- rac-trans-4-Desfluoro-4-methoxy Paroxetine Hydrochloride
- (3S,4R)-3-(1,3-Benzodioxol-5-yloxymethyl)-4-(4-methoxyphenyl)piperidine;hydrochloride
- trans-3S-Defluoro-4-methoxy Paroxetine Hydrochloride
- PAROXETINE HYDROCHLORIDE RELATED COMPOUND A [USP-RS]
- (3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)piperidine Hydrochloride
- Paroxetine USP Rc A; Paroxetine Hydrochloride Hemihydrate EP Impurity B
- Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-, hydrochloride (1:1), (3R,4S)-rel-
- (3S,4R)-3-((Benzodioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine hydrochloride
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-methoxyphenyl)piperidine hydrochloride
- (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-methoxyphenyl)piperidine,hydrochloride
- 3-((Benzodioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine hydrochloride, (3S,4R)-
- (3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine hydrochloride
- (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)piperidine Hydrochloride; (-)-Paroxetine-desfluoro methoxy hydrochloride
- (3S,4R)-3-{[(2H-1,3-Benzodioxol-5-yl)oxy]methyl}-4-(4-methoxyphenyl)piperidine--hydrogen chloride (1/1)
- 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-METHOXYPHENYL)PIPERIDINE HYDROCHLORIDE, TRANS-(+/-)-
- 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-METHOXYPHENYL)PIPERIDINE HYDROCHLORIDE, TRANS-(-)-
- 4-Methoxy Paroxetine; Paroxetine USP Related Compound A; ?rac-trans-4-Defluoro-4-methoxy Paroxetine Hydrochloride; (3R,4S)-rel-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)piperidine Hydrochloride; trans-(+/-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl) piperidine Hydrochloride
- PIPERIDINE, 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-METHOXYPHENYL)-, HYDROCHLORIDE, TRANS-(+/-)-
- PIPERIDINE, 3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-METHOXYPHENYL)-, HYDROCHLORIDE, TRANS-(-)-
- Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)-, hydrochloride (1:1), (3R,4S)-rel-; Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)-, hydrochloride, trans- (9CI); Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)-, hydrochloride, trans-(+/-)-; SB-242670-A; Ph Eur Paroxetine Hydrochloride Impurity B; p-Methoxy Paroxetine HCl; USP Paroxetine Related Compound A
- trans-(+/-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-methoxyphenyl)piperidine Hydrochloride